This inventor holds 3 USPTO granted patents and 4 published patent applications and 4 EPO patents. Top assignee: Sanofi. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Marc Bianciotto: Innovator in Pharmaceutical Research
Introduction: Marc Bianciotto is an accomplished inventor based in Paris, France. He is currently associated with Sanofi, a leading global healthcare company. Although he has not yet been granted any patents, his work in pharmaceutical research is noteworthy.
Latest Patent Applications: Marc Bianciotto has been involved in several significant patent applications. One of his latest applications is for "Pyrazolopyrazine Compounds as SHP2 Inhibitors." This application provides compounds and pharmaceutical compositions for modulating SHP2, which are intended for use in treating various diseases. Another notable application is for "Substituted Pyrrolo[2,3-D]Pyrimidines, Their Preparation and Their Therapeutic Application." This application discloses compounds that are useful as inhibitors of LRRK2 and are aimed at treating neurodegenerative diseases such as Parkinson's disease.
Conclusion: Marc Bianciotto's contributions to pharmaceutical research, particularly in the development of innovative compounds, highlight his potential impact in the field. His ongoing work at Sanofi continues to pave the way for advancements in medical treatments.